Juli Teague

736 total citations
6 papers, 473 citations indexed

About

Juli Teague is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Virology. According to data from OpenAlex, Juli Teague has authored 6 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 1 paper in Pathology and Forensic Medicine and 1 paper in Virology. Recurrent topics in Juli Teague's work include Ubiquitin and proteasome pathways (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and HIV Research and Treatment (1 paper). Juli Teague is often cited by papers focused on Ubiquitin and proteasome pathways (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and HIV Research and Treatment (1 paper). Juli Teague collaborates with scholars based in United States. Juli Teague's co-authors include Elizabeth Sinclair, Lorrie Epling, Peter W. Hunt, Mark Z. Jacobson, Lawrence Corey, Jeffrey N. Martin, Steven G. Deeks, Russell P. Tracy, Genhong Cheng and Andrea K. Miyahira and has published in prestigious journals such as Cancer Research, The Journal of Infectious Diseases and Molecular & Cellular Proteomics.

In The Last Decade

Juli Teague

6 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juli Teague United States	6	184	154	139	123	110	6	473
Christian Marsolais Canada	11	162 0.9×	79 0.5×	52 0.4×	84 0.7×	180 1.6×	28	488
Ketty Gianesin Italy	12	121 0.7×	132 0.9×	106 0.8×	66 0.5×	80 0.7×	18	431
Zheng D. Morrison United States	15	100 0.5×	138 0.9×	253 1.8×	40 0.3×	52 0.5×	16	489
Surada Lerdwana Thailand	11	121 0.7×	64 0.4×	57 0.4×	29 0.2×	105 1.0×	37	505
Stacey R. Vlahakis United States	9	267 1.5×	134 0.9×	266 1.9×	41 0.3×	100 0.9×	10	537
Bal Krishna Chand Thakuri United States	12	67 0.4×	80 0.5×	130 0.9×	29 0.2×	46 0.4×	15	339
Kelly M. Cheney Australia	11	168 0.9×	39 0.3×	112 0.8×	22 0.2×	87 0.8×	15	456
Lingyan Zhu China	14	90 0.5×	107 0.7×	394 2.8×	14 0.1×	88 0.8×	25	694
Dino B.A. Tan Australia	14	123 0.7×	153 1.0×	201 1.4×	13 0.1×	84 0.8×	34	565
Sun Suk Kim South Korea	8	40 0.2×	230 1.5×	78 0.6×	16 0.1×	46 0.4×	21	510

Countries citing papers authored by Juli Teague

Since Specialization

Citations

This map shows the geographic impact of Juli Teague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juli Teague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juli Teague more than expected).

Fields of papers citing papers by Juli Teague

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juli Teague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juli Teague. The network helps show where Juli Teague may publish in the future.

Co-authorship network of co-authors of Juli Teague

This figure shows the co-authorship network connecting the top 25 collaborators of Juli Teague. A scholar is included among the top collaborators of Juli Teague based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juli Teague. Juli Teague is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wang, Zhican, Ying Fang, Juli Teague, et al.. (2017). In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s. Drug Metabolism and Disposition. 45(7). 712–720. 18 indexed citations

2.

Federspiel, Joel D., Simona G. Codreanu, Sandeep Goyal, et al.. (2016). Specificity of Protein Covalent Modification by the Electrophilic Proteasome Inhibitor Carfilzomib in Human Cells. Molecular & Cellular Proteomics. 15(10). 3233–3242. 24 indexed citations

3.

Hunt, Peter W., Jeffrey N. Martin, Elizabeth Sinclair, et al.. (2011). Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy. The Journal of Infectious Diseases. 203(10). 1474–1483. 254 indexed citations

4.

Chin, Arnold I., Andrea K. Miyahira, Anthony J. Covarrubias, et al.. (2010). Toll-like Receptor 3–Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance. Cancer Research. 70(7). 2595–2603. 83 indexed citations

5.

DuBois, Steven G., C. Lorrie Epling, Juli Teague, Katherine K. Matthay, & Elizabeth Sinclair. (2009). Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow. Pediatric Blood & Cancer. 54(1). 13–18. 41 indexed citations

6.

Belmont, Brian J., Marc Evanchik, W. Michael Flanagan, et al.. (2009). SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo. Cancer Chemotherapy and Pharmacology. 65(4). 707–717. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact